| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Developmental Disabilities | 49 | 2024 | 211 | 8.910 |
Why?
|
| Infant, Premature | 43 | 2026 | 306 | 7.370 |
Why?
|
| Child Development | 39 | 2026 | 180 | 6.860 |
Why?
|
| Cerebral Palsy | 39 | 2025 | 101 | 6.250 |
Why?
|
| Activities of Daily Living | 21 | 2024 | 214 | 3.420 |
Why?
|
| Infant, Newborn | 85 | 2026 | 2531 | 3.250 |
Why?
|
| Infant, Premature, Diseases | 14 | 2025 | 83 | 3.170 |
Why?
|
| Child, Preschool | 96 | 2026 | 4006 | 3.040 |
Why?
|
| Intellectual Disability | 16 | 2026 | 202 | 2.810 |
Why?
|
| Child | 102 | 2026 | 7699 | 2.550 |
Why?
|
| Infant, Extremely Premature | 13 | 2025 | 45 | 2.450 |
Why?
|
| Infant | 60 | 2026 | 3332 | 1.990 |
Why?
|
| Zika Virus Infection | 7 | 2025 | 19 | 1.960 |
Why?
|
| Disability Evaluation | 15 | 2020 | 186 | 1.860 |
Why?
|
| Retinopathy of Prematurity | 10 | 2025 | 81 | 1.800 |
Why?
|
| Parenting | 4 | 2022 | 70 | 1.750 |
Why?
|
| Infant, Extremely Low Birth Weight | 6 | 2014 | 26 | 1.720 |
Why?
|
| Premature Birth | 6 | 2018 | 131 | 1.610 |
Why?
|
| Neuropsychological Tests | 18 | 2021 | 569 | 1.590 |
Why?
|
| Pregnancy Complications, Infectious | 6 | 2025 | 98 | 1.530 |
Why?
|
| Humans | 199 | 2026 | 98135 | 1.500 |
Why?
|
| Healthcare Disparities | 5 | 2024 | 539 | 1.490 |
Why?
|
| Health Services Accessibility | 7 | 2024 | 532 | 1.410 |
Why?
|
| Child Welfare | 7 | 2018 | 44 | 1.360 |
Why?
|
| Health Status Disparities | 4 | 2025 | 234 | 1.330 |
Why?
|
| Schools | 6 | 2024 | 93 | 1.230 |
Why?
|
| Intensive Care Units, Neonatal | 4 | 2024 | 74 | 1.210 |
Why?
|
| Bronchopulmonary Dysplasia | 7 | 2026 | 48 | 1.200 |
Why?
|
| Adolescent | 54 | 2025 | 10097 | 1.190 |
Why?
|
| Autism Spectrum Disorder | 6 | 2024 | 95 | 1.170 |
Why?
|
| Health Services Needs and Demand | 5 | 2018 | 102 | 1.140 |
Why?
|
| Quality of Life | 11 | 2026 | 1895 | 1.110 |
Why?
|
| Parent-Child Relations | 6 | 2024 | 89 | 1.110 |
Why?
|
| Autistic Disorder | 4 | 2018 | 155 | 1.100 |
Why?
|
| Female | 124 | 2026 | 51570 | 1.090 |
Why?
|
| Transition to Adult Care | 3 | 2023 | 28 | 1.080 |
Why?
|
| Zika Virus | 7 | 2025 | 20 | 1.050 |
Why?
|
| Male | 116 | 2026 | 47109 | 1.040 |
Why?
|
| Education, Special | 7 | 2024 | 9 | 1.030 |
Why?
|
| Gestational Age | 18 | 2025 | 341 | 0.990 |
Why?
|
| Down Syndrome | 7 | 2026 | 54 | 0.980 |
Why?
|
| Tracheostomy | 2 | 2024 | 48 | 0.980 |
Why?
|
| Motor Skills | 8 | 2020 | 80 | 0.970 |
Why?
|
| Infant, Very Low Birth Weight | 9 | 2009 | 51 | 0.940 |
Why?
|
| Neurodevelopmental Disorders | 8 | 2025 | 60 | 0.900 |
Why?
|
| Home Care Services | 2 | 2017 | 77 | 0.880 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 4 | 2026 | 123 | 0.880 |
Why?
|
| Cognition Disorders | 7 | 2018 | 240 | 0.870 |
Why?
|
| Social Support | 7 | 2012 | 246 | 0.870 |
Why?
|
| Executive Function | 6 | 2025 | 116 | 0.820 |
Why?
|
| Language Development Disorders | 5 | 2018 | 25 | 0.820 |
Why?
|
| Mental Health | 6 | 2018 | 219 | 0.810 |
Why?
|
| Parents | 8 | 2024 | 321 | 0.770 |
Why?
|
| Social Participation | 3 | 2018 | 17 | 0.760 |
Why?
|
| Motor Skills Disorders | 6 | 2018 | 14 | 0.740 |
Why?
|
| Crime Victims | 3 | 2018 | 59 | 0.730 |
Why?
|
| Psychological Tests | 3 | 2018 | 89 | 0.720 |
Why?
|
| Achondroplasia | 2 | 2012 | 9 | 0.710 |
Why?
|
| Educational Status | 7 | 2022 | 205 | 0.690 |
Why?
|
| Survivors | 3 | 2020 | 213 | 0.690 |
Why?
|
| Cognition | 8 | 2025 | 673 | 0.690 |
Why?
|
| Nervous System | 3 | 2020 | 92 | 0.680 |
Why?
|
| Prenatal Exposure Delayed Effects | 7 | 2025 | 183 | 0.680 |
Why?
|
| Pregnancy | 20 | 2025 | 3244 | 0.670 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2016 | 195 | 0.660 |
Why?
|
| Residence Characteristics | 3 | 2016 | 224 | 0.660 |
Why?
|
| Employment | 4 | 2020 | 66 | 0.660 |
Why?
|
| International Classification of Functioning, Disability and Health | 1 | 2020 | 2 | 0.640 |
Why?
|
| Poverty | 3 | 2015 | 215 | 0.640 |
Why?
|
| Registries | 8 | 2025 | 1122 | 0.630 |
Why?
|
| Family | 4 | 2020 | 327 | 0.620 |
Why?
|
| Socioeconomic Factors | 16 | 2025 | 663 | 0.610 |
Why?
|
| Sleep Wake Disorders | 3 | 2016 | 139 | 0.600 |
Why?
|
| Longitudinal Studies | 15 | 2025 | 1284 | 0.600 |
Why?
|
| Prevalence | 11 | 2024 | 1383 | 0.600 |
Why?
|
| Patient Discharge | 3 | 2022 | 381 | 0.600 |
Why?
|
| Infant, Newborn, Diseases | 5 | 2026 | 94 | 0.580 |
Why?
|
| Self Care | 7 | 2012 | 189 | 0.580 |
Why?
|
| Health Status | 10 | 2012 | 385 | 0.580 |
Why?
|
| Academic Performance | 1 | 2018 | 6 | 0.570 |
Why?
|
| Occupational Therapy | 1 | 2018 | 17 | 0.560 |
Why?
|
| Child Protective Services | 1 | 2018 | 5 | 0.560 |
Why?
|
| Diabetes Mellitus | 4 | 2026 | 811 | 0.560 |
Why?
|
| Motor Disorders | 1 | 2018 | 10 | 0.550 |
Why?
|
| United States | 21 | 2025 | 8193 | 0.540 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 40 | 0.530 |
Why?
|
| Referral and Consultation | 3 | 2019 | 418 | 0.530 |
Why?
|
| Adaptation, Psychological | 7 | 2018 | 190 | 0.520 |
Why?
|
| Family Characteristics | 2 | 2019 | 52 | 0.510 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 125 | 0.510 |
Why?
|
| Independent Living | 2 | 2018 | 33 | 0.510 |
Why?
|
| Social Environment | 3 | 2025 | 199 | 0.500 |
Why?
|
| Social Skills | 3 | 2018 | 9 | 0.490 |
Why?
|
| Psychomotor Performance | 4 | 2021 | 508 | 0.480 |
Why?
|
| Patient Transfer | 1 | 2017 | 113 | 0.480 |
Why?
|
| Pediatrics | 3 | 2025 | 421 | 0.480 |
Why?
|
| Psychological Trauma | 1 | 2016 | 11 | 0.480 |
Why?
|
| Nervous System Diseases | 7 | 2021 | 169 | 0.480 |
Why?
|
| Risk Factors | 21 | 2024 | 6232 | 0.480 |
Why?
|
| Infant Behavior | 2 | 2013 | 6 | 0.450 |
Why?
|
| Transitional Care | 1 | 2015 | 26 | 0.450 |
Why?
|
| Prospective Studies | 20 | 2026 | 4825 | 0.440 |
Why?
|
| Child Abuse | 1 | 2016 | 97 | 0.440 |
Why?
|
| Neurology | 2 | 2021 | 85 | 0.440 |
Why?
|
| Language | 1 | 2016 | 166 | 0.440 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2013 | 39 | 0.430 |
Why?
|
| Weight Gain | 1 | 2015 | 134 | 0.430 |
Why?
|
| Follow-Up Studies | 20 | 2026 | 4026 | 0.420 |
Why?
|
| Abnormalities, Multiple | 3 | 2015 | 235 | 0.410 |
Why?
|
| Family Relations | 3 | 2019 | 38 | 0.410 |
Why?
|
| Cohort Studies | 15 | 2025 | 3213 | 0.410 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 480 | 0.410 |
Why?
|
| Rett Syndrome | 5 | 2009 | 21 | 0.410 |
Why?
|
| Adult | 35 | 2025 | 29564 | 0.400 |
Why?
|
| Psychomotor Disorders | 2 | 2012 | 20 | 0.400 |
Why?
|
| Cross-Sectional Studies | 10 | 2025 | 2037 | 0.400 |
Why?
|
| Child Health Services | 3 | 2018 | 36 | 0.400 |
Why?
|
| Hydrocortisone | 2 | 2026 | 306 | 0.400 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2024 | 336 | 0.370 |
Why?
|
| Severity of Illness Index | 15 | 2025 | 2013 | 0.360 |
Why?
|
| Housing | 1 | 2012 | 51 | 0.360 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2012 | 7 | 0.360 |
Why?
|
| Health Promotion | 2 | 2019 | 176 | 0.360 |
Why?
|
| Social Determinants of Health | 3 | 2025 | 132 | 0.360 |
Why?
|
| Interpersonal Relations | 4 | 2020 | 182 | 0.350 |
Why?
|
| Surveys and Questionnaires | 13 | 2024 | 3022 | 0.350 |
Why?
|
| Population Surveillance | 4 | 2010 | 218 | 0.350 |
Why?
|
| Professional-Family Relations | 1 | 2012 | 60 | 0.350 |
Why?
|
| Length of Stay | 1 | 2015 | 878 | 0.340 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 802 | 0.340 |
Why?
|
| Obesity | 1 | 2018 | 1061 | 0.340 |
Why?
|
| Counseling | 2 | 2026 | 191 | 0.340 |
Why?
|
| Physician's Role | 1 | 2013 | 181 | 0.330 |
Why?
|
| Child Behavior | 3 | 2010 | 51 | 0.330 |
Why?
|
| Health Status Indicators | 5 | 2012 | 99 | 0.330 |
Why?
|
| Birth Weight | 5 | 2012 | 150 | 0.320 |
Why?
|
| Bioethics | 1 | 2011 | 37 | 0.320 |
Why?
|
| Interviews as Topic | 1 | 2012 | 387 | 0.320 |
Why?
|
| Australia | 4 | 2021 | 125 | 0.310 |
Why?
|
| Genetic Testing | 2 | 2012 | 594 | 0.310 |
Why?
|
| Attention | 1 | 2014 | 435 | 0.300 |
Why?
|
| Neonatal Screening | 5 | 2012 | 71 | 0.300 |
Why?
|
| Treatment Outcome | 8 | 2026 | 9713 | 0.290 |
Why?
|
| Central Nervous System | 1 | 2010 | 144 | 0.290 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 339 | 0.290 |
Why?
|
| Child Nutrition Disorders | 1 | 2008 | 13 | 0.280 |
Why?
|
| Young Adult | 10 | 2025 | 7511 | 0.280 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 2 | 2026 | 3 | 0.280 |
Why?
|
| Ventilators, Mechanical | 3 | 2024 | 44 | 0.280 |
Why?
|
| Infant Mortality | 2 | 2007 | 68 | 0.270 |
Why?
|
| Behavior Therapy | 1 | 2009 | 100 | 0.270 |
Why?
|
| Brain | 5 | 2016 | 2448 | 0.270 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2008 | 48 | 0.260 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 685 | 0.260 |
Why?
|
| Sensation Disorders | 1 | 2007 | 33 | 0.260 |
Why?
|
| Aging | 1 | 2013 | 771 | 0.260 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 658 | 0.260 |
Why?
|
| Morbidity | 2 | 2001 | 162 | 0.260 |
Why?
|
| Mothers | 3 | 2019 | 146 | 0.260 |
Why?
|
| Child of Impaired Parents | 1 | 2007 | 20 | 0.250 |
Why?
|
| Preventive Health Services | 1 | 2007 | 38 | 0.250 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 2555 | 0.250 |
Why?
|
| Clinical Competence | 1 | 2013 | 865 | 0.250 |
Why?
|
| Congenital Abnormalities | 2 | 1999 | 69 | 0.250 |
Why?
|
| Regression Analysis | 7 | 2014 | 580 | 0.250 |
Why?
|
| Deglutition Disorders | 5 | 1994 | 126 | 0.250 |
Why?
|
| Movement | 3 | 2022 | 315 | 0.240 |
Why?
|
| Developing Countries | 1 | 2007 | 101 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2016 | 3618 | 0.240 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2011 | 508 | 0.240 |
Why?
|
| Analysis of Variance | 7 | 2012 | 889 | 0.240 |
Why?
|
| Practice Guidelines as Topic | 3 | 2011 | 1109 | 0.240 |
Why?
|
| Medical Oncology | 1 | 2010 | 421 | 0.240 |
Why?
|
| Anxiety | 2 | 2026 | 370 | 0.230 |
Why?
|
| Mutation | 4 | 2016 | 4392 | 0.230 |
Why?
|
| Sick Role | 1 | 2005 | 13 | 0.230 |
Why?
|
| Psychometrics | 4 | 2012 | 357 | 0.230 |
Why?
|
| Social Adjustment | 1 | 2005 | 46 | 0.230 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2012 | 104 | 0.230 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 3 | 2010 | 58 | 0.220 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2025 | 86 | 0.220 |
Why?
|
| White Matter | 2 | 2016 | 100 | 0.220 |
Why?
|
| Meningomyelocele | 1 | 2005 | 27 | 0.220 |
Why?
|
| Epilepsy | 4 | 2013 | 447 | 0.220 |
Why?
|
| Infant, Low Birth Weight | 3 | 2000 | 62 | 0.220 |
Why?
|
| Respiration, Artificial | 3 | 2024 | 462 | 0.220 |
Why?
|
| Risk | 3 | 2016 | 660 | 0.220 |
Why?
|
| Brain Diseases | 1 | 2006 | 175 | 0.220 |
Why?
|
| Time Factors | 6 | 2018 | 5576 | 0.220 |
Why?
|
| Case-Control Studies | 6 | 2025 | 1996 | 0.210 |
Why?
|
| Health Services | 2 | 2003 | 55 | 0.210 |
Why?
|
| Anxiety Disorders | 2 | 2023 | 160 | 0.210 |
Why?
|
| Mother-Child Relations | 2 | 2019 | 30 | 0.210 |
Why?
|
| Colombia | 4 | 2025 | 20 | 0.200 |
Why?
|
| Particulate Matter | 1 | 2025 | 138 | 0.200 |
Why?
|
| Siblings | 3 | 2026 | 113 | 0.200 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 842 | 0.200 |
Why?
|
| Air Pollutants | 1 | 2025 | 116 | 0.200 |
Why?
|
| Environment | 1 | 2025 | 233 | 0.200 |
Why?
|
| Air Pollution | 1 | 2025 | 119 | 0.200 |
Why?
|
| Canada | 2 | 2021 | 211 | 0.200 |
Why?
|
| Fish Products | 1 | 2003 | 3 | 0.200 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2003 | 8 | 0.200 |
Why?
|
| Feasibility Studies | 3 | 2024 | 803 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2026 | 358 | 0.190 |
Why?
|
| Maternal Exposure | 1 | 2003 | 68 | 0.190 |
Why?
|
| Neuroimaging | 1 | 2024 | 143 | 0.190 |
Why?
|
| Vision Disorders | 3 | 2014 | 74 | 0.190 |
Why?
|
| Mobile Applications | 1 | 2024 | 83 | 0.190 |
Why?
|
| Intestinal Perforation | 1 | 2022 | 38 | 0.180 |
Why?
|
| Microcephaly | 1 | 2022 | 77 | 0.180 |
Why?
|
| Students | 2 | 2009 | 196 | 0.180 |
Why?
|
| Bevacizumab | 2 | 2023 | 255 | 0.180 |
Why?
|
| Life Change Events | 1 | 2022 | 49 | 0.180 |
Why?
|
| Environmental Exposure | 1 | 2025 | 405 | 0.180 |
Why?
|
| Self Concept | 2 | 2021 | 139 | 0.170 |
Why?
|
| Water Pollutants, Chemical | 1 | 2003 | 156 | 0.170 |
Why?
|
| New York | 5 | 2009 | 79 | 0.170 |
Why?
|
| Pain | 1 | 2024 | 416 | 0.170 |
Why?
|
| Social Class | 4 | 2024 | 156 | 0.170 |
Why?
|
| Depression | 3 | 2025 | 615 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2022 | 155 | 0.160 |
Why?
|
| Chronic Pain | 1 | 2023 | 203 | 0.160 |
Why?
|
| Bacteroidetes | 1 | 2021 | 40 | 0.160 |
Why?
|
| Emotions | 2 | 2023 | 387 | 0.160 |
Why?
|
| Attitude to Health | 2 | 2003 | 217 | 0.160 |
Why?
|
| Communication Disorders | 1 | 2000 | 7 | 0.160 |
Why?
|
| Chicago | 3 | 2024 | 1513 | 0.160 |
Why?
|
| Video Recording | 4 | 2024 | 220 | 0.160 |
Why?
|
| Checklist | 1 | 2021 | 78 | 0.160 |
Why?
|
| Patient Care | 1 | 2021 | 100 | 0.150 |
Why?
|
| Sepsis | 1 | 2004 | 427 | 0.150 |
Why?
|
| Public Policy | 3 | 2011 | 61 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2003 | 985 | 0.150 |
Why?
|
| Medical Marijuana | 1 | 2019 | 11 | 0.140 |
Why?
|
| Laser Coagulation | 1 | 2019 | 56 | 0.140 |
Why?
|
| Pregnancy, Multiple | 1 | 2018 | 37 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 1012 | 0.140 |
Why?
|
| Literacy | 1 | 2018 | 2 | 0.140 |
Why?
|
| Term Birth | 1 | 2018 | 8 | 0.140 |
Why?
|
| Health Surveys | 3 | 2007 | 254 | 0.140 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 334 | 0.140 |
Why?
|
| Pilot Projects | 3 | 2025 | 977 | 0.140 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 3 | 1988 | 11 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2023 | 484 | 0.140 |
Why?
|
| Achievement | 2 | 2012 | 30 | 0.140 |
Why?
|
| Sex Factors | 4 | 2018 | 1138 | 0.140 |
Why?
|
| Telemedicine | 1 | 2021 | 250 | 0.140 |
Why?
|
| Child Health | 1 | 2018 | 15 | 0.130 |
Why?
|
| Reproducibility of Results | 7 | 2021 | 2787 | 0.130 |
Why?
|
| Probability | 1 | 2018 | 356 | 0.130 |
Why?
|
| Health Policy | 2 | 2010 | 216 | 0.130 |
Why?
|
| Depressive Disorder | 1 | 2018 | 231 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2019 | 280 | 0.130 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 303 | 0.130 |
Why?
|
| Blindness | 4 | 2025 | 41 | 0.130 |
Why?
|
| Comorbidity | 2 | 2013 | 1031 | 0.130 |
Why?
|
| Health Behavior | 1 | 2018 | 200 | 0.130 |
Why?
|
| Legal Guardians | 1 | 2016 | 7 | 0.120 |
Why?
|
| Lipids | 1 | 2018 | 293 | 0.120 |
Why?
|
| Urea | 2 | 1988 | 54 | 0.120 |
Why?
|
| Hospitals, University | 2 | 2016 | 192 | 0.120 |
Why?
|
| Hypothermia | 1 | 2016 | 27 | 0.120 |
Why?
|
| Patient Participation | 1 | 2018 | 246 | 0.120 |
Why?
|
| Health Personnel | 1 | 2019 | 258 | 0.120 |
Why?
|
| Erythropoietin | 1 | 2016 | 90 | 0.120 |
Why?
|
| Child Behavior Disorders | 1 | 2016 | 76 | 0.120 |
Why?
|
| Multicenter Studies as Topic | 2 | 2006 | 200 | 0.110 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2016 | 59 | 0.110 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 209 | 0.110 |
Why?
|
| Ear | 1 | 1995 | 18 | 0.110 |
Why?
|
| Sexual Behavior | 2 | 2016 | 340 | 0.110 |
Why?
|
| Intelligence | 3 | 2025 | 68 | 0.110 |
Why?
|
| Exercise | 1 | 2018 | 380 | 0.110 |
Why?
|
| Logistic Models | 5 | 2018 | 1275 | 0.110 |
Why?
|
| Retrospective Studies | 9 | 2024 | 10962 | 0.110 |
Why?
|
| Inhalation | 2 | 1994 | 34 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2018 | 850 | 0.110 |
Why?
|
| Pregnancy in Diabetics | 1 | 1995 | 43 | 0.110 |
Why?
|
| Self Report | 1 | 2016 | 355 | 0.110 |
Why?
|
| Neurologic Examination | 5 | 2013 | 120 | 0.110 |
Why?
|
| Intelligence Tests | 3 | 2025 | 38 | 0.110 |
Why?
|
| Visual Fields | 1 | 2014 | 101 | 0.110 |
Why?
|
| Mass Screening | 3 | 2010 | 745 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2018 | 910 | 0.100 |
Why?
|
| Stress, Psychological | 3 | 2008 | 383 | 0.100 |
Why?
|
| Ocular Motility Disorders | 1 | 2014 | 16 | 0.100 |
Why?
|
| Functional Laterality | 1 | 2015 | 207 | 0.100 |
Why?
|
| Aftercare | 2 | 2022 | 91 | 0.100 |
Why?
|
| Fixation, Ocular | 1 | 2014 | 49 | 0.100 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2022 | 84 | 0.100 |
Why?
|
| Communication | 2 | 2012 | 456 | 0.100 |
Why?
|
| Emotional Intelligence | 1 | 2013 | 22 | 0.100 |
Why?
|
| Spine | 1 | 1995 | 148 | 0.100 |
Why?
|
| North America | 2 | 2024 | 210 | 0.100 |
Why?
|
| Metabolism, Inborn Errors | 2 | 2003 | 30 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 661 | 0.090 |
Why?
|
| Phenotype | 6 | 2013 | 2638 | 0.090 |
Why?
|
| Censuses | 1 | 2012 | 12 | 0.090 |
Why?
|
| Hospitalization | 2 | 2017 | 991 | 0.090 |
Why?
|
| Adaptation, Physiological | 2 | 2012 | 349 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 1784 | 0.090 |
Why?
|
| Cryotherapy | 2 | 2004 | 31 | 0.090 |
Why?
|
| Mortality | 1 | 1993 | 159 | 0.090 |
Why?
|
| Medulloblastoma | 1 | 2012 | 44 | 0.090 |
Why?
|
| Cerebellar Neoplasms | 1 | 2012 | 44 | 0.090 |
Why?
|
| Sulfonylurea Compounds | 1 | 2012 | 73 | 0.090 |
Why?
|
| Learning | 2 | 2021 | 310 | 0.090 |
Why?
|
| Ultrasonography | 3 | 2014 | 720 | 0.090 |
Why?
|
| Language Development | 1 | 2012 | 22 | 0.090 |
Why?
|
| Radiotherapy, Conformal | 1 | 2012 | 88 | 0.090 |
Why?
|
| Telephone | 1 | 2012 | 43 | 0.090 |
Why?
|
| Motor Activity | 2 | 2009 | 331 | 0.090 |
Why?
|
| Wheelchairs | 1 | 1991 | 8 | 0.090 |
Why?
|
| Hearing Loss | 2 | 2019 | 68 | 0.090 |
Why?
|
| Enteral Nutrition | 3 | 2021 | 104 | 0.080 |
Why?
|
| Multivariate Analysis | 4 | 2024 | 1009 | 0.080 |
Why?
|
| Transportation | 1 | 1991 | 26 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2012 | 282 | 0.080 |
Why?
|
| International Cooperation | 1 | 2011 | 132 | 0.080 |
Why?
|
| Diagnosis, Differential | 5 | 2010 | 1568 | 0.080 |
Why?
|
| Family Health | 2 | 2008 | 156 | 0.080 |
Why?
|
| Leukomalacia, Periventricular | 3 | 2009 | 19 | 0.080 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 233 | 0.080 |
Why?
|
| Science | 1 | 2011 | 39 | 0.080 |
Why?
|
| Rhode Island | 2 | 2007 | 11 | 0.080 |
Why?
|
| Victoria | 1 | 2010 | 5 | 0.080 |
Why?
|
| Atlanto-Axial Joint | 1 | 1990 | 13 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 134 | 0.080 |
Why?
|
| Research | 1 | 2011 | 257 | 0.080 |
Why?
|
| Neural Tube Defects | 2 | 2004 | 39 | 0.080 |
Why?
|
| Incidence | 3 | 2012 | 1777 | 0.080 |
Why?
|
| Reading | 1 | 2009 | 34 | 0.080 |
Why?
|
| Maternal Age | 2 | 2024 | 49 | 0.070 |
Why?
|
| Middle Aged | 9 | 2025 | 29442 | 0.070 |
Why?
|
| Allied Health Occupations | 1 | 2009 | 1 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2010 | 286 | 0.070 |
Why?
|
| Psychology | 1 | 2009 | 28 | 0.070 |
Why?
|
| Faculty | 1 | 2009 | 40 | 0.070 |
Why?
|
| Professional Role | 1 | 2009 | 40 | 0.070 |
Why?
|
| Joint Instability | 1 | 1990 | 105 | 0.070 |
Why?
|
| Caffeine | 1 | 1989 | 87 | 0.070 |
Why?
|
| Psychology, Adolescent | 1 | 2008 | 26 | 0.070 |
Why?
|
| Intracranial Hemorrhages | 1 | 2009 | 138 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 568 | 0.070 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 92 | 0.070 |
Why?
|
| Clinical Nursing Research | 1 | 2007 | 2 | 0.070 |
Why?
|
| Pediatric Nursing | 1 | 2007 | 6 | 0.070 |
Why?
|
| Prognosis | 2 | 2010 | 4116 | 0.070 |
Why?
|
| Nursing Assessment | 1 | 2007 | 20 | 0.070 |
Why?
|
| House Calls | 1 | 2007 | 13 | 0.070 |
Why?
|
| Single Parent | 1 | 2007 | 2 | 0.060 |
Why?
|
| Psychosocial Deprivation | 1 | 2007 | 4 | 0.060 |
Why?
|
| Women's Health | 1 | 2008 | 119 | 0.060 |
Why?
|
| Interview, Psychological | 1 | 2007 | 70 | 0.060 |
Why?
|
| Pharynx | 4 | 1994 | 43 | 0.060 |
Why?
|
| Decision Making | 1 | 2012 | 686 | 0.060 |
Why?
|
| Fathers | 1 | 2007 | 46 | 0.060 |
Why?
|
| Gender Identity | 1 | 2007 | 59 | 0.060 |
Why?
|
| Videotape Recording | 1 | 2006 | 50 | 0.060 |
Why?
|
| Fluoroscopy | 4 | 1994 | 138 | 0.060 |
Why?
|
| Health Education | 1 | 2007 | 109 | 0.060 |
Why?
|
| Age Factors | 5 | 2009 | 1967 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2007 | 164 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2022 | 2585 | 0.060 |
Why?
|
| Deglutition | 4 | 1994 | 87 | 0.060 |
Why?
|
| Aphasia | 1 | 1986 | 19 | 0.060 |
Why?
|
| Genomics | 1 | 2012 | 898 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 2009 | 377 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1948 | 0.060 |
Why?
|
| Disease Progression | 1 | 2010 | 1610 | 0.060 |
Why?
|
| Nigeria | 1 | 2025 | 174 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2005 | 230 | 0.050 |
Why?
|
| Maternal Health | 1 | 2024 | 2 | 0.050 |
Why?
|
| Caregivers | 1 | 2006 | 201 | 0.050 |
Why?
|
| School Health Services | 1 | 2024 | 19 | 0.050 |
Why?
|
| Rural Population | 1 | 2025 | 191 | 0.050 |
Why?
|
| Urban Population | 1 | 2025 | 246 | 0.050 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2024 | 169 | 0.050 |
Why?
|
| Food, Fortified | 1 | 2004 | 18 | 0.050 |
Why?
|
| Cocaine | 2 | 1998 | 84 | 0.050 |
Why?
|
| Folic Acid | 1 | 2004 | 69 | 0.050 |
Why?
|
| Walking | 2 | 2005 | 114 | 0.050 |
Why?
|
| Fresh Water | 1 | 2003 | 21 | 0.050 |
Why?
|
| Food Contamination | 1 | 2003 | 37 | 0.050 |
Why?
|
| Fetal Development | 1 | 2003 | 37 | 0.050 |
Why?
|
| Pregnancy Trimester, First | 1 | 2003 | 65 | 0.050 |
Why?
|
| Brain Injuries | 2 | 2016 | 143 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2023 | 107 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2004 | 152 | 0.050 |
Why?
|
| Muscle Spasticity | 1 | 2022 | 10 | 0.050 |
Why?
|
| Smartphone | 1 | 2023 | 53 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2003 | 69 | 0.050 |
Why?
|
| Life Style | 1 | 2003 | 193 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2023 | 401 | 0.040 |
Why?
|
| Television | 2 | 1999 | 28 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 2658 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2021 | 63 | 0.040 |
Why?
|
| Internet | 1 | 2024 | 358 | 0.040 |
Why?
|
| Negotiating | 1 | 2021 | 19 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2003 | 277 | 0.040 |
Why?
|
| Social Behavior | 1 | 2004 | 316 | 0.040 |
Why?
|
| Respite Care | 1 | 2001 | 8 | 0.040 |
Why?
|
| New Zealand | 1 | 2001 | 24 | 0.040 |
Why?
|
| Sweden | 1 | 2001 | 48 | 0.040 |
Why?
|
| Genetics, Behavioral | 1 | 2000 | 22 | 0.040 |
Why?
|
| Intensive Care, Neonatal | 1 | 2020 | 15 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 226 | 0.040 |
Why?
|
| New England | 1 | 2000 | 10 | 0.040 |
Why?
|
| Patient Admission | 1 | 2001 | 123 | 0.040 |
Why?
|
| Alberta | 1 | 2020 | 11 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2002 | 225 | 0.040 |
Why?
|
| Delivery, Obstetric | 1 | 2021 | 120 | 0.040 |
Why?
|
| Head | 1 | 2021 | 135 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 49 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2000 | 198 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2001 | 174 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2016 | 1783 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2003 | 447 | 0.040 |
Why?
|
| Vision, Low | 1 | 2019 | 15 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 1751 | 0.040 |
Why?
|
| Intravitreal Injections | 1 | 2019 | 69 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 314 | 0.040 |
Why?
|
| Pregnancy, Twin | 1 | 2018 | 12 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 387 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 1998 | 17 | 0.040 |
Why?
|
| Academic Success | 1 | 2018 | 11 | 0.030 |
Why?
|
| Asphyxia Neonatorum | 1 | 1998 | 7 | 0.030 |
Why?
|
| Body Height | 1 | 1998 | 109 | 0.030 |
Why?
|
| Narcotics | 1 | 1998 | 74 | 0.030 |
Why?
|
| Models, Biological | 1 | 2005 | 1809 | 0.030 |
Why?
|
| Hypoxia | 2 | 1993 | 699 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2019 | 726 | 0.030 |
Why?
|
| Barium Sulfate | 2 | 1994 | 37 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2000 | 1527 | 0.030 |
Why?
|
| Body Weight | 1 | 1998 | 455 | 0.030 |
Why?
|
| Oxygen | 1 | 2022 | 801 | 0.030 |
Why?
|
| Pneumonia, Aspiration | 2 | 1994 | 20 | 0.030 |
Why?
|
| Seizures | 2 | 2013 | 324 | 0.030 |
Why?
|
| Neurologic Manifestations | 1 | 2016 | 10 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1120 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 360 | 0.030 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2009 | 18 | 0.030 |
Why?
|
| Food | 2 | 1994 | 93 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 212 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 916 | 0.030 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 2 | 1986 | 4 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2013 | 829 | 0.030 |
Why?
|
| Ammonia | 2 | 1986 | 38 | 0.030 |
Why?
|
| Hearing Loss, Bilateral | 1 | 1995 | 10 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 881 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 7387 | 0.030 |
Why?
|
| Visual Perception | 1 | 2018 | 350 | 0.030 |
Why?
|
| Visual Field Tests | 1 | 2014 | 16 | 0.030 |
Why?
|
| Acidosis | 1 | 2014 | 55 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2016 | 302 | 0.030 |
Why?
|
| Neural Crest | 1 | 1995 | 35 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 839 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 2014 | 66 | 0.030 |
Why?
|
| Mesoderm | 1 | 1995 | 122 | 0.030 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 1995 | 79 | 0.030 |
Why?
|
| Cineradiography | 1 | 1994 | 9 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 1995 | 116 | 0.030 |
Why?
|
| Pulmonary Surfactants | 1 | 1994 | 22 | 0.030 |
Why?
|
| Projection | 1 | 1993 | 1 | 0.030 |
Why?
|
| Mouth | 1 | 1994 | 53 | 0.030 |
Why?
|
| Orientation | 1 | 2014 | 111 | 0.020 |
Why?
|
| Gastrostomy | 1 | 1994 | 67 | 0.020 |
Why?
|
| Aspirin | 1 | 2014 | 169 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2011 | 1090 | 0.020 |
Why?
|
| Survival Rate | 1 | 1997 | 2041 | 0.020 |
Why?
|
| Placenta | 1 | 2014 | 203 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 255 | 0.020 |
Why?
|
| Cranial Irradiation | 1 | 2012 | 42 | 0.020 |
Why?
|
| Retina | 1 | 2014 | 221 | 0.020 |
Why?
|
| World Health Organization | 1 | 2012 | 125 | 0.020 |
Why?
|
| Induction Chemotherapy | 1 | 2012 | 151 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 365 | 0.020 |
Why?
|
| Spinal Cord Compression | 1 | 1991 | 50 | 0.020 |
Why?
|
| Safety | 1 | 1991 | 138 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1990 | 20 | 0.020 |
Why?
|
| Spinal Stenosis | 1 | 1991 | 53 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 206 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 1993 | 267 | 0.020 |
Why?
|
| Acetaminophen | 1 | 1990 | 63 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2009 | 26 | 0.020 |
Why?
|
| Xanthines | 1 | 1989 | 3 | 0.020 |
Why?
|
| Kidney | 1 | 1995 | 1123 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 1193 | 0.020 |
Why?
|
| Brain Damage, Chronic | 2 | 1991 | 19 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 220 | 0.020 |
Why?
|
| Uracil | 1 | 1989 | 58 | 0.020 |
Why?
|
| Aged | 3 | 2025 | 21760 | 0.020 |
Why?
|
| Acetylation | 1 | 1989 | 151 | 0.020 |
Why?
|
| Reoperation | 1 | 2012 | 726 | 0.020 |
Why?
|
| Fetus | 1 | 1990 | 237 | 0.020 |
Why?
|
| Scoliosis | 1 | 2009 | 43 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2009 | 118 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1989 | 308 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1995 | 687 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 1991 | 250 | 0.020 |
Why?
|
| Arm | 1 | 1988 | 100 | 0.020 |
Why?
|
| Coma | 2 | 1986 | 46 | 0.020 |
Why?
|
| Health Maintenance Organizations | 1 | 1987 | 18 | 0.020 |
Why?
|
| Comprehensive Health Care | 1 | 1987 | 13 | 0.020 |
Why?
|
| Observer Variation | 2 | 2000 | 579 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 795 | 0.020 |
Why?
|
| Movement Disorders | 1 | 2006 | 44 | 0.020 |
Why?
|
| Paralysis | 1 | 2005 | 33 | 0.010 |
Why?
|
| Muscle Hypotonia | 1 | 2005 | 47 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 1535 | 0.010 |
Why?
|
| Heterozygote | 1 | 1986 | 390 | 0.010 |
Why?
|
| Argininosuccinate Synthase | 1 | 1984 | 1 | 0.010 |
Why?
|
| Argininosuccinic Aciduria | 1 | 1984 | 1 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2006 | 160 | 0.010 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 1984 | 5 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 1888 | 0.010 |
Why?
|
| Anencephaly | 1 | 2004 | 7 | 0.010 |
Why?
|
| Spinal Dysraphism | 1 | 2004 | 27 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2003 | 215 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 191 | 0.010 |
Why?
|
| Biotinidase Deficiency | 1 | 2002 | 1 | 0.010 |
Why?
|
| Homocystinuria | 1 | 2002 | 2 | 0.010 |
Why?
|
| Galactosemias | 1 | 2002 | 2 | 0.010 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2002 | 5 | 0.010 |
Why?
|
| Western Australia | 1 | 2002 | 1 | 0.010 |
Why?
|
| Oximetry | 2 | 1993 | 94 | 0.010 |
Why?
|
| Education | 1 | 2000 | 59 | 0.010 |
Why?
|
| Protein-Energy Malnutrition | 1 | 1998 | 4 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1990 | 2680 | 0.010 |
Why?
|
| Anthropometry | 1 | 1998 | 77 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1997 | 176 | 0.010 |
Why?
|
| Age Distribution | 1 | 1997 | 208 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1255 | 0.010 |
Why?
|
| Fontan Procedure | 1 | 1995 | 58 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1996 | 508 | 0.010 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 1994 | 3 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1984 | 2668 | 0.010 |
Why?
|
| Barium | 1 | 1993 | 32 | 0.010 |
Why?
|
| Cough | 1 | 1993 | 61 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 1994 | 129 | 0.010 |
Why?
|
| Airway Obstruction | 1 | 1993 | 112 | 0.010 |
Why?
|
| Respiration | 1 | 1993 | 275 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1994 | 320 | 0.010 |
Why?
|
| Intervertebral Disc Displacement | 1 | 1991 | 48 | 0.010 |
Why?
|
| Heart Rate | 1 | 1993 | 536 | 0.000 |
Why?
|
| Spinal Cord | 1 | 1991 | 244 | 0.000 |
Why?
|
| Algorithms | 1 | 1997 | 2009 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1990 | 674 | 0.000 |
Why?
|
| Dyslexia | 1 | 1988 | 12 | 0.000 |
Why?
|
| Genetic Carrier Screening | 1 | 1986 | 58 | 0.000 |
Why?
|
| X Chromosome | 1 | 1986 | 154 | 0.000 |
Why?
|
| Substance-Related Disorders | 1 | 1990 | 470 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1986 | 613 | 0.000 |
Why?
|
| Pedigree | 1 | 1986 | 980 | 0.000 |
Why?
|